Cargando…
ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival
Invasive squamous cell carcinoma (SCC) is aggressive cancer with a high risk of recurrence and metastasis, but the critical determinants of its progression remain elusive. Here, we identify ADAP1, a GTPase-activating protein (GAP) for ARF6 up-regulated in TGF-β-responding invasive tumor cells, as a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892435/ https://www.ncbi.nlm.nih.gov/pubmed/31792062 http://dx.doi.org/10.26508/lsa.201900582 |
_version_ | 1783476028435333120 |
---|---|
author | Van Duzer, Avery Taniguchi, Sachiko Elhance, Ajit Tsujikawa, Takahiro Oshimori, Naoki |
author_facet | Van Duzer, Avery Taniguchi, Sachiko Elhance, Ajit Tsujikawa, Takahiro Oshimori, Naoki |
author_sort | Van Duzer, Avery |
collection | PubMed |
description | Invasive squamous cell carcinoma (SCC) is aggressive cancer with a high risk of recurrence and metastasis, but the critical determinants of its progression remain elusive. Here, we identify ADAP1, a GTPase-activating protein (GAP) for ARF6 up-regulated in TGF-β-responding invasive tumor cells, as a strong predictor of poor survival in early-stage SCC patients. Using a mouse model of SCC, we show that ADAP1 overexpression promotes invasive tumor progression by facilitating cell migration and breakdown of the basement membrane. We found that ADAP1-rich, TGF-β-responding tumor cells exhibit cytoplasmic laminin localization, which correlated with the absence of laminin and type IV collagen from the pericellular basement membrane. Interestingly, although tumors overexpressing a GAP activity-deficient mutant of ADAP1 resulted in morphologically complex tumors, those tumor cells failed to breach the basement membrane. Moreover, Adap1 deletion in tumor cells ameliorated the basement membrane breakdown and had less invading cells in the stroma. Our study demonstrates that ADAP1 is a critical mediator of TGF-β-induced cancer invasion and might be exploited for the treatment of high-risk SCC. |
format | Online Article Text |
id | pubmed-6892435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-68924352019-12-06 ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival Van Duzer, Avery Taniguchi, Sachiko Elhance, Ajit Tsujikawa, Takahiro Oshimori, Naoki Life Sci Alliance Research Articles Invasive squamous cell carcinoma (SCC) is aggressive cancer with a high risk of recurrence and metastasis, but the critical determinants of its progression remain elusive. Here, we identify ADAP1, a GTPase-activating protein (GAP) for ARF6 up-regulated in TGF-β-responding invasive tumor cells, as a strong predictor of poor survival in early-stage SCC patients. Using a mouse model of SCC, we show that ADAP1 overexpression promotes invasive tumor progression by facilitating cell migration and breakdown of the basement membrane. We found that ADAP1-rich, TGF-β-responding tumor cells exhibit cytoplasmic laminin localization, which correlated with the absence of laminin and type IV collagen from the pericellular basement membrane. Interestingly, although tumors overexpressing a GAP activity-deficient mutant of ADAP1 resulted in morphologically complex tumors, those tumor cells failed to breach the basement membrane. Moreover, Adap1 deletion in tumor cells ameliorated the basement membrane breakdown and had less invading cells in the stroma. Our study demonstrates that ADAP1 is a critical mediator of TGF-β-induced cancer invasion and might be exploited for the treatment of high-risk SCC. Life Science Alliance LLC 2019-12-02 /pmc/articles/PMC6892435/ /pubmed/31792062 http://dx.doi.org/10.26508/lsa.201900582 Text en © 2019 Van Duzer et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Articles Van Duzer, Avery Taniguchi, Sachiko Elhance, Ajit Tsujikawa, Takahiro Oshimori, Naoki ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
title | ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
title_full | ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
title_fullStr | ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
title_full_unstemmed | ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
title_short | ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
title_sort | adap1 promotes invasive squamous cell carcinoma progression and predicts patient survival |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892435/ https://www.ncbi.nlm.nih.gov/pubmed/31792062 http://dx.doi.org/10.26508/lsa.201900582 |
work_keys_str_mv | AT vanduzeravery adap1promotesinvasivesquamouscellcarcinomaprogressionandpredictspatientsurvival AT taniguchisachiko adap1promotesinvasivesquamouscellcarcinomaprogressionandpredictspatientsurvival AT elhanceajit adap1promotesinvasivesquamouscellcarcinomaprogressionandpredictspatientsurvival AT tsujikawatakahiro adap1promotesinvasivesquamouscellcarcinomaprogressionandpredictspatientsurvival AT oshimorinaoki adap1promotesinvasivesquamouscellcarcinomaprogressionandpredictspatientsurvival |